Strides Arcolab gets ANDA nod for flumazenil injection

New Delhi, May 14 (UNI) Pharma major Strides Arcolab Ltd today said it has received abbreviated new drug application (ANDA) approval from the United States Food and Drug Administration (USFDA) for flumazenil injection.

''Flumazenil injection is licensed to Akom-Strides LLC, a joint venture between Akorn Inc and Strides,'' the company said in a statement.

Flumazenil is used to reverse the sedative effects of tranquilisers.

UNI AK BJR RN1709